期刊文献+

B19病毒VP1u蛋白对胎鼠心脏的影响 被引量:1

Pathogenic effects of B19 VPlu protein on heart of fetal mice
下载PDF
导出
摘要 目的探讨B19病毒vplu蛋白是否影响心脏发育及相关机制。方法对不同孕龄母鼠注射B19病毒vplu蛋白,采集胎鼠心脏组织标本,通过光镜、电镜、免疫组织化学、TUNEL和原位杂交技术观察心脏细胞结构变化、细胞凋亡及相关基因或表面标志物变化。结果实验期间有23只小鼠怀孕,vplu蛋白和(或)抗vplu蛋白mAh干预组与对照组均未见胎鼠流产。各组产仔数量及鼠心脏重量进行组间方差分析,差异无显著性(P>0.05)。vplu蛋白和(或)抗VPIu蛋白mAl干预组光镜下均可见心肌细胞间隙增宽,胞质透明淡染,部分心肌细胞脂肪变性。电镜下vplu蛋白(或)和vplu蛋白mAh共同注射组、抗VPIu蛋白mAb注射组均可见线粒体聚集在增宽的心肌细胞间隙中,有空泡化,并TUNEL免疫荧光和免疫组织化学显示心肌细胞发生细胞凋亡。对照组胎鼠均未见异常。结论B19病毒vplu蛋白与胎鼠流产、心脏发育畸形无关,与胎鼠心脏水肿有关。 Objectives To explore the pathogenic effects of B19 VPIu protein on heart development and its probable mechanisms.Methods B19 VPlu protein was injected into mice at different gestational age,then the cardiac tissue specimens of fetal mice were harvested.The structural changes of cardiac cells were observed by light microscope and electron microscope.Cell apoptosis and surface biomarkers were detected by immunohistochemistry,TUNEL and in situ hybridization techniques.ResultsThere were 23 pregnant mice and no fetal abortion in VPIu protein group,VPlu protein mAh intervention group or control group during the experiment.Heart weight and the number of descendants in each group were analyzed by variance,which shows no statistical difference with P>0.05.Widened myocardial cell gaps,transparent or pale cytoplasm and cardiac steatosis were detected by light microscope in the groups of VP1u protein group and VPIu protein mAb intervention group.Mitochondria with vacuolation gathered in the widened gaps between myocardial cells,and cardiac cell apoptosis were detected by immunohistochemical and immunofluorescence techniques,while there was no abnormalities in control group.Conclusion B19 VPIu protein has no effects on fetal abortion and fetal heart malformation,hut is associated with cardiac edema of fetal mouse.
出处 《发育医学电子杂志》 2013年第1期11-15,共5页 Journal of Developmental Medicine (Electronic Version)
基金 国家自然科学基金资助项目(81070543)
关键词 人细小病毒 VP1u蛋白 胎鼠 心脏 Human parvovirus VPIu protein Fetal mouse Heart
  • 相关文献

参考文献13

  • 1Mori J,Beattie P,Melton D W. Structure and mapping of the DNA of human parvovirus B19[J].Journal of General Virology,1987.2797-2806.
  • 2Maisch B,Richter A,Koelsch S. Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy[J].Herz,2006.881-890.
  • 3Schenk T,Enders M,Pollak S. High prevalence of human parvovirus B19 DNA in myocardial.autopsy samples from subjects without myocarditis or dilative cardiomyopathy[J].Journal of Clinical Microbiology,2009.106-110.
  • 4Wang X,Zhang G,Liu F. Prevalence of human B19 DNA in cardiac tissues of patients with congenital heant diseases indicated by nested PCR and in situ hybridization[J].Journal of Clinical Virology,2004.20-24.
  • 5王晓明,张国成,韩美玉.先天性心脏病心肌活检组织中微小病毒感染的定位[J].中华实验和临床病毒学杂志,2000,14(2):175-177. 被引量:5
  • 6许东亮,张国成,李飚,王晓明,孙新.胎儿人细小病毒B19感染与孕妇自然流产及胎儿先天性畸形的关系[J].中华妇产科杂志,2002,37(6):324-326. 被引量:23
  • 7Quemelo PR,Lima DM,da Fonseca BA. Detection of parvovirus B19 infection in formalin-fixed and paraffinembedded placenta and fetal tissues[J].Revista Do Instituto De Medicina Tropical De Sao Paulo,2007.103-107.
  • 8Savarese I,De Carolis MP,Costa S. Atypical manifestations of congenital parvovirus B19 infection[J].European Journal of Pediatrics,2008.1463-1466.
  • 9Von Kaisenberg CS,Grebe S,Schleider S. Successful intrauterine intracardiac transfusion in monochorionic twins affected by parvovirus B19[J].Fetal Diagnosis and Therapy,2007.420-424.
  • 10Zuffi E,Manaresi E,Gallinella G. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans[J].Viral Immunology,2001.151-158.

二级参考文献2

共引文献24

同被引文献29

  • 1蔡文勤,张元珍.微小病毒B19与早期自然流产关系的研究[J].武汉大学学报(医学版),2007,28(1):109-112. 被引量:6
  • 2COSSART Y E, FIELD A M, CANT B, et al. Parvovir- us-like particles in human sera [Jl. Lancet, 1975, 1 (7898) :72 - 73.
  • 3ROSENFELD S J, YOSHIMOTO K, KAJIGAYA S, et al. Unique region of the m~nor capsid protein of human parvovirus B19 is exposed on the virion surface I J~. J Clin Invest, 1992, 89(6): 2023.
  • 4CORCORAN A, DOYLE S. Advances in the biology, di- agnosis and host-pathogen interactions of parvovirus B19[J]. J Med Microbiol, 2004,53(6) :459 -475.
  • 5SA1KAWA T, ANDERSON S, MOMOEDA M, et al. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions [ J]. J Virol, 1993, 67(6) : 3004 -3009.
  • 6LAMONT R F, SOBEL J D, VAISBUCH E, et al. Par- vovirus B19 infection in human pregnancy [ J]. BJOG, 2011, 118(2) : 175 -186.
  • 7ENDERS M, WEIDNER A, ENDERS G. Current epide- miological aspects of human parvovirus B19 infection dur- ing pregnancy and childhood in the western part of Ger- many [ J ]. Epidemiol Infect,2007,135 ( 4 ) : 563 - 569.
  • 8ABIODUN I, OPALEYE O O, OJURONGBE O, et al. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo -State, Nigeria [ J ]. J In- feet Dev Ctries,2013,7(12) :946 -950.
  • 9BROWN T, ANAND A, RITCHIE L D, et al. Intrauter- ine parvovirus infection associated with hydrops fetalis [J]. Lancet,1984,324(8410) :1033 - 1034.
  • 10WEIFFENBACH J, BALD R, GLONING K P, et al. Se- rological and virological analysis of maternal and fetal blood samples in prenatal human parvovirus b19 infection [Jl. J Infect Dis,2012,205(5) :782 -788.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部